The Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center, Department of Cardiology, Torrance, CA, USA.
The Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center, Department of Cardiology, Torrance, CA, USA.
Clin Nutr ESPEN. 2020 Dec;40:327-335. doi: 10.1016/j.clnesp.2020.08.007. Epub 2020 Sep 7.
This study assessed efficacy of plant based bioequivalent nitrate complex, consist of vitamins, natural antioxidants and phytophenol rich food extracts to elevate nitric oxide (NO) bioavailability as determined by saliva conversion of nitrate (NO) to nitrite (NO) a required step to produce NO, in relationship to lowering blood pressure (BP) in both men and women.
67 individuals (26 men; mean age of 59.3 ± 9.0 yrs) with mean baseline systolic and diastolic BP >120 and 80 mmHg respectively were randomized to receive daily dosing of 314 mM NO or NO free (placebo) tablets in double-blinded study for 12 weeks (wks). Inorganic NO tablets consist of NO rich beetroot extract, thiamine nitrate, and potassium nitrate in the presence of ascorbic acid, to facilitate NO bioavailability.
The primary endpoint of the study was reduction in BP at 12 wks by improving endothelial function. At study conclusion, mean ± SD reduction in systolic BP (SBP) in the inorganic NO group was 12.5 ± 13.3 mmHg (p = 0.0007), as compared to 6.19 ± 11.39 mmHg (p = 0.004) in the placebo group, for a placebo-corrected reduction of -6.31 mmHg (95% CI 10.89-2.31, p = 0.04). NO also reduced diastolic BP by 4.7 ± 10.3 mmHg (p = 0.01), while no significant reduction in placebo group (1.98 ± 9.38 mmHg, p = 0.24) was noted. Endothelial function improved at 12 weeks by 0.8 ± 3.1 (p = 0.03) in active group when compared to 0.1 ± 1.8 (p = 0.82) in placebo group.
Endothelial function improved robustly reducing both systolic and diastolic BP in hypertensive individuals with daily supplementation of dietary NO. CLINICALTRIALS.
NCT03909789.
本研究评估了植物源性生物等效硝酸盐复合物的疗效,该复合物由维生素、天然抗氧化剂和富含植物酚的食物提取物组成,可提高一氧化氮(NO)的生物利用度,通过唾液将硝酸盐(NO)转化为亚硝酸盐(NO)来确定,这是产生 NO 的必需步骤,与降低男性和女性的血压(BP)有关。
67 名个体(26 名男性;平均年龄 59.3±9.0 岁),平均基线收缩压和舒张压分别大于 120 和 80mmHg,随机分为每日服用 314mMNO 或无 NO(安慰剂)片剂的双盲研究,为期 12 周(wk)。无机 NO 片剂由富含硝酸盐的甜菜根提取物、硝酸硫胺素和硝酸钾组成,同时含有抗坏血酸,以促进 NO 的生物利用度。
该研究的主要终点是通过改善内皮功能来降低 12 周时的血压。研究结束时,无机 NO 组的收缩压(SBP)平均下降 12.5±13.3mmHg(p=0.0007),而安慰剂组下降 6.19±11.39mmHg(p=0.004),安慰剂校正后下降-6.31mmHg(95%CI10.89-2.31,p=0.04)。NO 还使舒张压降低 4.7±10.3mmHg(p=0.01),而安慰剂组无显著降低(1.98±9.38mmHg,p=0.24)。与安慰剂组相比,内皮功能在 12 周时改善了 0.8±3.1(p=0.03)。
每日补充膳食 NO 可显著改善高血压个体的内皮功能,降低收缩压和舒张压。
临床试验.gov 注册号:NCT03909789。